News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
192 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (22990)
Month
January (2722)
February (2862)
March (3369)
April (3287)
May (3419)
June (3649)
July (3258)
August (3461)
September (3585)
October (3789)
November (3817)
December (2398)
Day
1 (152)
2 (136)
3 (91)
6 (192)
7 (159)
8 (144)
9 (142)
10 (104)
13 (133)
14 (149)
15 (136)
16 (126)
17 (88)
20 (134)
21 (98)
22 (115)
27 (125)
28 (61)
29 (54)
30 (59)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
6
7
8
9
10
13
14
15
16
17
20
21
22
27
28
29
30
Business
MabCure, Inc. Welcomes Dr. Charles T. Tackney as New Chief Scientific Officer
December 6, 2010
·
2 min read
Drug Development
Celgene International Sárl Release: Phase III Study Evaluating REVLIMID(R) in Patients with High-Risk Smoldering Multiple Myeloma Reported Statistically Significant Reduction in Risk of Disease Progression
December 6, 2010
·
1 min read
Drug Development
ImmunoGen, Inc. Announces Presentation of Positive Initial Clinical Data for IMGN901 Used in a Combination Regimen for Multiple Myeloma
December 6, 2010
·
1 min read
Drug Development
Array BioPharma, Inc.'s Arry-520 Demonstrates Single Agent Activity in Advanced Multiple Myeloma Patients
December 6, 2010
·
1 min read
Drug Development
US Oncology, Inc. Research Investigators Participated in Studies That Will be Presented at the 2010 American Society of Hematology Annual Meeting and Exposition
December 6, 2010
·
4 min read
Drug Development
Telik, Inc. Announces Final Positive Phase 2 Results of a Multicenter Study of Oral Ezatiostat Hydrochloride (TELINTRA(R), TLK199) in Patients with Myelodysplastic Syndrome
December 6, 2010
·
12 min read
Drug Development
S*Bio’s Novel JAK2 Inhibitor SB1518 Is Shown to Be a Safe and Effective Therapy in Phase 1/2 Studies For Patients with Symptomatic Myelofibrosis and Relapsed/Refractory Lymphoma
December 6, 2010
·
6 min read
Business
unithink NV Names John Cline CEO
December 6, 2010
·
2 min read
Pharm Country
Regeneron Pharmaceuticals, Inc. Announces Presentation at the 2010 Deutsche Bank BioFest
December 6, 2010
·
1 min read
Business
Biodel Inc. to Report Fourth Quarter Fiscal Year 2010 Financial Results on December 9, 2010
December 6, 2010
·
1 min read
Previous
7 of 20
Next
